Financials

  • Market Capitalization 225.74 M
  • Employee 51
  • Founded 2006
  • CEO N/A
  • Website www.protaratx.com
  • Headquarter New York, United States
  • FIGI BBG001ZLYSH5
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.98
Relación precio/flujo de caja
4 659.52

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3516
TNXP
Tonix Pharmaceuticals Holding Corp. - Common Stock
13.58 USD+0.15%+8.21%+35.80%-9.53%232.91 M USD
3524
RNA
Atrium Therapeutics, Inc. - Common Stock
13.63 USD-2.50%+3.26%+19.46%-80.62%233.15 M USD
3558
DTIL
Precision BioSciences, Inc. - Common Stock
7.78 USD-7.38%-12.09%+8.51%+53.15%214.74 M USD
3562
CHRS
Coherus Oncology, Inc. - Common Stock
1.41 USD-3.42%-0.70%-2.08%-12.42%217.85 M USD

Noticias